The Annual Methods Summit convenes health policy leaders, health care executives, patient leaders, and researchers to address critical challenges in patient-centered value assessment. During the 2021 Methods Summit, IVI convened key leaders to build answers and consensus on the key questions: “What are the most important data inputs to represent patient preferences and patient outcomes?” and “How can we harness this data to drive insights in patient-centered outcomes research and value assessment?”

The 2021 Methods Summit was a virtual, three-day event that will include plenary sessions open to the public, as well as invitation-only small and large group events.

Event Details


The primary goal was to convene and facilitate discussions among patients and other stakeholders—including researchers, providers, and payers—to build consensus on how to define, collect, and use data that more fully represent the impacts on patients of disease and treatment options. Specific project objectives included:

  • Evaluating current research that informs the conceptualization, collection, and use of patient-derived data on patient preferences, outcomes, and impacts
  • Prioritizing and standardize target elements of patient inputs relevant to specific decision contexts
  • Prioritizing methods research and other action needed to address gaps in the collection and use of data on patient inputs as part of patient-centered outcomes research (PCOR), comparative clinical effectiveness research (CER), and value assessment
  • Defining and empowering best practice in the collection and use of patient inputs data on a large scale


Inclusion of diverse inputs and perspectives from a representative patient population is essential to ensure that the research enterprise—from clinical and comparative effectiveness to outcomes and value assessment—captures the diversity of patient preferences and treatment experiences in the real world, and yields credible and relevant insights to inform decisions. Patient perspectives on value may differ from that of medical providers or other decision makers. Standardized measures and methods for collecting and scaling inputs on patient preference in real-world settings are lacking.

Proposed Solution to the Problem

IVI will convene a multi-stakeholder summit series to derive consensus on patient inputs that more fully represent impacts on patients of their health conditions and health care. Through this summit, IVI and its partners will engage patient leaders and stakeholders across the healthcare landscape to prioritize the methods for collection of relevant data that better represents what matters to patients.

Event Sponsorship

Sponsorship of IVI’s Annual Methods Summit event enables you to engage with trusted leaders in health care to advance innovation and new ideas for how we answer some of today’s most daunting questions about measuring value.

If you are interested in becoming a sponsor of the next IVI Methods Summit, click below to contact Melanie Ridley, Director of Fund Development and Partnerships.

Words from Our Thought Leaders and Experts from the 2020 Methods Summit

Jennifer Bright, MPA
Jennifer Bright, MPAExecutive Director, Innovation and Value Initiative
“It was gratifying to bring together such a committed cross-section of health care leaders to really dive into a complex discussion of how to improve the methods we’re using to measure and compare value of health interventions. There is strong agreement that we need to collectively invest in improving the data inputs – particularly representing patient preferences and outcomes – and work to define how novel methods and value assessment tools can offer insights in context to unique decision makers. “
Lou Garrison, PhD
Lou Garrison, PhDProfessor Emeritus, University of Washington
“IVI’s ability to bring this diverse group together is key, and it is never easy…It was a pleasure and an honor to participate in this lively and important discussion with implications for where we researchers need to focus our efforts in the months and years to come to meaningfully improve value assessment. No doubt, these participants and many others will want to carry forward this work.”